A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 242 participants.
Also called NCT06749457
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 242 participants
- Sponsor
- Registry
-
NCT06749457
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06749457. Randomized; quadruple masking; primary purpose prevention. Start 2024-12-30 (actual); primary completion 2027-03-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Acronym
- PEAK
- Condition
- Staphylococcus Aureus
- Intervention (Drug)
- AZD7760
- Intervention (Other)
- Placebo
- Lead sponsor
- AstraZeneca
- Collaborator
- Parexel
Record details
- Record id
cardio:ct-nct06749457- Content hash
2c52a2c29c5fb7dcd4d2f821197bd278632f332570cda3ea97735fe14da3f41e